Awards as PI
| Award Value | ||
|---|---|---|
| Disease Team Therapy Planning I | A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants | $90,147 |
| Transplantation Immunology | Purified allogeneic hematopoietic stem cells as a platform for tolerance induction | $1,233,275 |
| Disease Team Therapy Development - Research | A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants | $19,068,382 |
Total: $20,391,804.00 |
Awards as Co-PI
Publications
- Curr Opin Immunol 2012 The road to purified hematopoietic stem cell transplants is paved with antibodies. (PubMed: 22939368)
Search CIRM grants
Follow Us
